when fda approve compass pathways' comp360 psilocybin
Before Jan 1, 2027
when fda approve compass pathways' comp360 psilocybin. Best Yes near 19¢ across 1 platform. Live cross-platform prices. Not financial advice.
Best Yes: 19¢ · Best No: 88¢ · 1 platform
- Kalshi: Yes 19¢ / No 88¢
LIVE
Before Jan 1, 2027
Volume
$187
$0 24h
Platforms
1
Cross-platform pricing
Resolution
Resolves Jan 1, 2027
~199 days left
Category
Culture
Yes
19¢
Kalshi
No
88¢
Kalshi
Opens on best-price platform
Compare & Trade
1 platform
Price History
Loading…
About This Market
If the FDA approves COMP360 Psilocybin for Treatment-Resistant Depression for marketing before Jan 1, 2027, then the market resolves to Yes.
Market Details
ResolutionResolves Jan 1, 2027
Time Left199 days
Status● Active
CategoryCulture
Yes
19¢
Kalshi
Payout 5.3x
No
88¢
Kalshi
Payout 1.1x
Opens on best-price platform
Compare & Trade
1 platformSign in to join the discussion
Sign In